Importantly, this novel dPCR assay could be extended to identify BRAF V600E status in biopsies from other types of cancer, such as melanoma, non–small cell lung cancer, colon cancer, colorectal cancer, and ovarian cancer, in the context of precision medicine. This evidence concerns the gene BRAF and colorectal cancer.